These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8996492)
1. Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Munschauer FE; Priore RL; Hens M; Castilone A Stroke; 1997 Jan; 28(1):72-6. PubMed ID: 8996492 [TBL] [Abstract][Full Text] [Related]
2. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators. Can J Cardiol; 1998 May; 14(5):695-702. PubMed ID: 9627526 [TBL] [Abstract][Full Text] [Related]
3. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888 [TBL] [Abstract][Full Text] [Related]
4. Quality of care for atrial fibrillation among patients hospitalized for heart failure. Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC; J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670 [TBL] [Abstract][Full Text] [Related]
5. [Atrial fibrillation and thromboembolic events prevention. State of the art]. Matteoli S; Trappolini M; Chillotti FM Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381 [TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications. Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27402230 [TBL] [Abstract][Full Text] [Related]
7. Atrial fibrillation and stroke prevention in the community. O'Connell JE; Gray CS Age Ageing; 1996 Jul; 25(4):307-9. PubMed ID: 8831876 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. Verheugt FWA; Gao H; Al Mahmeed W; Ambrosio G; Angchaisuksiri P; Atar D; Bassand JP; Camm AJ; Cools F; Eikelboom J; Kayani G; Lim TW; Misselwitz F; Pieper KS; van Eickels M; Kakkar AK; Eur Heart J; 2018 Feb; 39(6):464-473. PubMed ID: 29281086 [TBL] [Abstract][Full Text] [Related]
9. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation. Yu HC; Tsai YF; Chen MC; Yeh CH Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland. Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227 [TBL] [Abstract][Full Text] [Related]
11. How to define valvular atrial fibrillation? Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867 [TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: prevalence and management in an acute general medical unit. Stewart FM; Singh Y; Persson S; Gamble GD; Braatvedt GD Aust N Z J Med; 1999 Feb; 29(1):51-8. PubMed ID: 10200813 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310 [TBL] [Abstract][Full Text] [Related]
14. Warfarin use in nursing home residents: results from the 2004 national nursing home survey. Ghaswalla PK; Harpe SE; Slattum PW Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690 [TBL] [Abstract][Full Text] [Related]
15. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. Mendelson G; Aronow WS J Am Geriatr Soc; 1998 Nov; 46(11):1423-4. PubMed ID: 9809766 [TBL] [Abstract][Full Text] [Related]
16. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237 [TBL] [Abstract][Full Text] [Related]
17. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry. Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013 [TBL] [Abstract][Full Text] [Related]
18. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Cowan C; Healicon R; Robson I; Long WR; Barrett J; Fay M; Tyndall K; Gale CP Heart; 2013 Aug; 99(16):1166-72. PubMed ID: 23393083 [TBL] [Abstract][Full Text] [Related]
19. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508 [TBL] [Abstract][Full Text] [Related]
20. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]